XML 49 R33.htm IDEA: XBRL DOCUMENT v3.25.1

Stockholders’ Deficit (Tables)

12 Months Ended

Dec. 31, 2024

Stockholders’ Deficit [Abstract]

Schedule of Compensation Expense Related Restricted Stock Awards

The table below summarizes the compensation expense related to the Company’s restricted stock awards for the years ended December 31:

		2024				2023
Directors
October 1, 2024 – 1,914,580 Directors’ share grant of common stock		$	623,000			$	-
February 23, 2023 - 168,419 share grant of common stock			109,000				190,000
Consultants
December 5, 2024 – 58,644 share grant of common stock			-				20,000
August 23, 2023 – 48,000 share grant of common stock			-				24,000
October 26, 2021 – 17,724 share grant of common stock			-				129,000
October 22, 2021 – 8,637 share grant for common stock			-				66,000
October 20, 2021 – 17,724 share grant for common stock			-				154,000
Employees
December 17, 2024 – VP Energy 500,000 share grant of common stock			5,000				-
September 30, 2024 – CEO 1,671,682 share grant of common stock			454,000				-
June 19, 2023 – CFO 675,058 share grant of common stock			397,000				530,000
April 4, 2022 – CFO 166,667 share grant of common stock			-				395,000
Stock-based compensation expense reversal for April 4, 2022 grant			-				(1,910,000	)
Other
Officer contributed capital			-				250,000
		$	1,588,000			$	(152,000	)

Schedule of Service-Based RSUs

The following table presents a summary of the activity of the RSUs:

		Number of Units				Weighted Average Grant-date er Share Fair Value
Balance as of December 31, 2022			-				-
Granted			843,478			$	1.51
Vested			(112,508	)		$	1.40
Forfeited			-			$	-
Balance as of December 31, 2023			730,970			$	1.53
Granted			4,086,261			$	0.62
Vested			(196,720	)		$	1.56
Forfeited			-			$	-
Balance as of December 31, 2024			4,620,511			$	0.73

Schedule of Warrants Transactions

Transactions involving warrants are as follows for the year ended December 31,:

2024		Number of Shares				Weighted Average Strike Price/Share				Weighted Average Remaining Contractual Term (Years)				Weighted Average Grant Date Fair Value				Weighted Average Intrinsic Value
Outstanding – December 31, 2023			1,844,781			$	9.84				0.55			$	1.36			$	-
Granted			5,530,198				0.55				9.68				0.55				0.39
Exercised			(165,622	)			0.006				0.75				9.06				1.48
Expired			(1,679,159	)			10.98				-				7.55				-
Outstanding – December 31, 2024			5,530,198				0.55				9.68				0.55				0.39
Exercisable – December 31, 2024			5,530,198				0.55				9.68				0.55				0.39
Non-exercisable – December 31, 2024			-			$	-				-			$	-			$	-

2023		Number of Shares				Weighted Average Strike Price/Share				Weighted Average Remaining Contractual Term (Years)				Weighted Average Grant Date Fair Value				Weighted Average Intrinsic Value
Outstanding – December 31, 2022			1,844,781			$	9.84				1.39			$	1.36			$	-
Granted			-				-				-				-				-
Exercised			-				-				-				-				-
Expired			-				-				-				-				-
Outstanding – December 31, 2023			1,844,781				9.84				0.55				1.36				-
Exercisable – December 31, 2023			1,844,781				9.84				0.55				1.36				-
Non-exercisable – December 31, 2023			-			$	-				-			$	-			$	-

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-1

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration